Vitamin D and proteinuria: a critical review of molecular bases and clinical experience
Vitamina D y proteinuria: revisión crítica de las bases moleculares y de la experiencia clínica
Read
18619
Timeswas read the article
3991
Total PDF
14628
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 80 | 34 | 114 |
| 2025 5 | 210 | 80 | 290 |
| 2025 4 | 158 | 54 | 212 |
| 2025 3 | 205 | 65 | 270 |
| 2025 2 | 175 | 39 | 214 |
| 2025 1 | 152 | 43 | 195 |
| 2024 12 | 115 | 43 | 158 |
| 2024 11 | 112 | 58 | 170 |
| 2024 10 | 70 | 64 | 134 |
| 2024 9 | 94 | 44 | 138 |
| 2024 8 | 128 | 86 | 214 |
| 2024 7 | 97 | 51 | 148 |
| 2024 6 | 116 | 81 | 197 |
| 2024 5 | 101 | 47 | 148 |
| 2024 4 | 99 | 54 | 153 |
| 2024 3 | 87 | 37 | 124 |
| 2024 2 | 58 | 44 | 102 |
| 2024 1 | 92 | 51 | 143 |
| 2023 12 | 77 | 42 | 119 |
| 2023 11 | 79 | 50 | 129 |
| 2023 10 | 74 | 83 | 157 |
| 2023 9 | 69 | 56 | 125 |
| 2023 8 | 65 | 42 | 107 |
| 2023 7 | 87 | 53 | 140 |
| 2023 6 | 82 | 68 | 150 |
| 2023 5 | 81 | 51 | 132 |
| 2023 4 | 69 | 28 | 97 |
| 2023 3 | 74 | 45 | 119 |
| 2023 2 | 58 | 36 | 94 |
| 2023 1 | 57 | 38 | 95 |
| 2022 12 | 81 | 42 | 123 |
| 2022 11 | 50 | 42 | 92 |
| 2022 10 | 80 | 53 | 133 |
| 2022 9 | 90 | 34 | 124 |
| 2022 8 | 73 | 52 | 125 |
| 2022 7 | 78 | 63 | 141 |
| 2022 6 | 100 | 42 | 142 |
| 2022 5 | 89 | 46 | 135 |
| 2022 4 | 80 | 37 | 117 |
| 2022 3 | 93 | 74 | 167 |
| 2022 2 | 99 | 51 | 150 |
| 2022 1 | 150 | 68 | 218 |
| 2021 12 | 84 | 59 | 143 |
| 2021 11 | 110 | 45 | 155 |
| 2021 10 | 127 | 64 | 191 |
| 2021 9 | 98 | 50 | 148 |
| 2021 8 | 86 | 48 | 134 |
| 2021 7 | 101 | 48 | 149 |
| 2021 6 | 89 | 31 | 120 |
| 2021 5 | 118 | 51 | 169 |
| 2021 4 | 237 | 58 | 295 |
| 2021 3 | 97 | 43 | 140 |
| 2021 2 | 98 | 38 | 136 |
| 2021 1 | 90 | 34 | 124 |
| 2020 12 | 93 | 24 | 117 |
| 2020 11 | 109 | 23 | 132 |
| 2020 10 | 93 | 23 | 116 |
| 2020 9 | 70 | 15 | 85 |
| 2020 8 | 70 | 29 | 99 |
| 2020 7 | 96 | 22 | 118 |
| 2020 6 | 99 | 27 | 126 |
| 2020 5 | 87 | 25 | 112 |
| 2020 4 | 79 | 18 | 97 |
| 2020 3 | 111 | 30 | 141 |
| 2020 2 | 104 | 37 | 141 |
| 2020 1 | 126 | 30 | 156 |
| 2019 12 | 158 | 30 | 188 |
| 2019 11 | 129 | 45 | 174 |
| 2019 10 | 86 | 27 | 113 |
| 2019 9 | 123 | 25 | 148 |
| 2019 8 | 135 | 46 | 181 |
| 2019 7 | 112 | 33 | 145 |
| 2019 6 | 95 | 24 | 119 |
| 2019 5 | 180 | 42 | 222 |
| 2019 4 | 172 | 57 | 229 |
| 2019 3 | 118 | 40 | 158 |
| 2019 2 | 97 | 33 | 130 |
| 2019 1 | 73 | 36 | 109 |
| 2018 12 | 142 | 42 | 184 |
| 2018 11 | 113 | 25 | 138 |
| 2018 10 | 135 | 16 | 151 |
| 2018 9 | 200 | 25 | 225 |
| 2018 8 | 168 | 26 | 194 |
| 2018 7 | 125 | 17 | 142 |
| 2018 6 | 113 | 20 | 133 |
| 2018 5 | 123 | 26 | 149 |
| 2018 4 | 102 | 13 | 115 |
| 2018 3 | 124 | 15 | 139 |
| 2018 2 | 88 | 10 | 98 |
| 2018 1 | 110 | 16 | 126 |
| 2017 12 | 87 | 10 | 97 |
| 2017 11 | 115 | 10 | 125 |
| 2017 10 | 103 | 8 | 111 |
| 2017 9 | 82 | 6 | 88 |
| 2017 8 | 98 | 11 | 109 |
| 2017 7 | 122 | 24 | 146 |
| 2017 6 | 137 | 7 | 144 |
| 2017 5 | 140 | 17 | 157 |
| 2017 4 | 124 | 14 | 138 |
| 2017 3 | 132 | 24 | 156 |
| 2017 2 | 192 | 17 | 209 |
| 2017 1 | 113 | 8 | 121 |
| 2016 12 | 113 | 13 | 126 |
| 2016 11 | 165 | 13 | 178 |
| 2016 10 | 243 | 22 | 265 |
| 2016 9 | 375 | 12 | 387 |
| 2016 8 | 410 | 22 | 432 |
| 2016 7 | 302 | 21 | 323 |
| 2016 6 | 203 | 0 | 203 |
| 2016 5 | 194 | 0 | 194 |
| 2016 4 | 190 | 0 | 190 |
| 2016 3 | 158 | 0 | 158 |
| 2016 2 | 169 | 0 | 169 |
| 2016 1 | 144 | 0 | 144 |
| 2015 12 | 173 | 0 | 173 |
| 2015 11 | 134 | 0 | 134 |
| 2015 10 | 152 | 0 | 152 |
| 2015 9 | 124 | 0 | 124 |
| 2015 8 | 104 | 0 | 104 |
| 2015 7 | 90 | 0 | 90 |
| 2015 6 | 67 | 0 | 67 |
| 2015 5 | 84 | 0 | 84 |
| 2015 4 | 12 | 0 | 12 |
Show all
